Status:
COMPLETED
Assessment of Autogenous Dentin Graft in Treatment of Infra-bony Defect
Lead Sponsor:
October 6 University
Conditions:
Periodontitis (Stage 3)
Eligibility:
All Genders
16-50 years
Phase:
NA
Brief Summary
The aim of the present study was to evaluate the effect of demineralized autogenous dentine on treatment of infrabony defects.
Detailed Description
In this study, the investigators tested the effect of demineralized autogenous dentine as a bone graft in treatment of stage III periodontitis in term of probing pocket depth reduction, mean gain in c...
Eligibility Criteria
Inclusion
- Patients with good systemic health and no contraindication for periodontal surgery.
- Patients who are able to maintain good oral hygiene.
- Gingival thickness for the site selected should be ≥1mm.
- Probing depth of ≥ 6mm.
- Patient has at least one hopeless teeth
Exclusion
- Active infectious diseases (hepatitis, tubercu¬losis, HIV, etc….).
- Medically compromised patients.
- Smokers and alcoholic abusers
- People who suffer from any systemic disease that affect the periodontium.
- Pregnant, postmenopausal women.
- People who take anti-inflammatory drugs, anti¬biotics or vitamins within the previous 3 month.
- People who use mouth washes regularly
- Participants in other clinical trials.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05258006
Start Date
January 1 2021
End Date
January 1 2022
Last Update
February 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
October 6 University
Cairo, Egypt